Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA OKs New Anemia Med That Challenges Amgen
FDA OKs New Anemia Med That Challenges Amgen
FDA OKs New Anemia Med That Challenges Amgen
Submitted by
admin
on March 28, 2012 - 11:27am
Source:
Pharmalot
News Tags:
FDA
Amgen
anemia
Epogen
Omontys
Affymax
Aranesp
Headline:
FDA OKs New Anemia Med That Challenges Amgen
Do Not Allow Advertisers to Use My Personal information
